Exploratory Study of Prognostic Plasma Biomarkers in Patients with Pulmonary Arterial Hypertension
Yukimitsu Kuwabara, Olivier Boucherat, Tetsuro Yokokawa(Fukushima Medical University), Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), François Potus(Queen's University), Sandra Breuils‐Bonnet, Mélanie Sauvaget(Canadian Heart Research Centre), Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Sandra Martineau(Canadian Heart Research Centre)
Cited by 2
Related Papers
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
Novel Mutations and Decreased Expression of the Epigenetic Regulator <i>TET2</i> in Pulmonary Arterial Hypertension
|Circulation|2020|120
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
|Genetics in Medicine|2023|73
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension
|American Journal of Respiratory and Critical Care Medicine|2020|34
ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changes
|Science Translational Medicine|2024|33